Biologically, non-small cell lung cancer (NSCLC) tumor xenografts with reduced USP8 protein expression, when treated with SAIT301, significantly demonstrated a reduction in tumoral growth and of c-Met expression compared to the non-treated group. The gene discussed is MET; the disease is non-small cell lung carcinoma.